HMII Technology Design

Click image to enlarge

The HeartMate II

The HeartMate II left ventricle assist device (LVAD), the gold standard in LVAD therapy, combines precision engineering with simple and elegant design—a single moving part, open flow paths for optimized blood flow, highly durable ruby bearings, a flexible inflow conduit to accommodate reverse remodeling of the heart, and textured surfaces to reduce the risk of thrombosis. The result: maximized reliability, minimized adverse events, and restored life for thousands of patients.

The HeartMate II pumps blood throughout the body at up to ten liters per minute, the full output of a healthy heart—and with a dramatically reduced footprint compared to other approved LVADs, the HeartMate II is suitable for a broad range of patients, including women and persons of smaller stature.

Since receiving the European CE Mark in November 2005, allowing for commercial sale in Europe, the HeartMate II has continued to break
barriers, becoming the first and only continuous flow device approved
by the FDA for both the Bridge-to-Transplantation (BTT) and Destination Therapy (DT) indications.